BioCorRx (BICX) Receivables - Other (2016 - 2025)
Historic Receivables - Other for BioCorRx (BICX) over the last 10 years, with Q3 2025 value amounting to $761515.0.
- BioCorRx's Receivables - Other rose 14238.95% to $761515.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $761515.0, marking a year-over-year increase of 14238.95%. This contributed to the annual value of $76266.0 for FY2023, which is 3781.92% down from last year.
- Latest data reveals that BioCorRx reported Receivables - Other of $761515.0 as of Q3 2025, which was up 14238.95% from $153728.0 recorded in Q2 2025.
- BioCorRx's Receivables - Other's 5-year high stood at $958111.0 during Q2 2022, with a 5-year trough of $1500.0 in Q1 2021.
- Over the past 5 years, BioCorRx's median Receivables - Other value was $101081.0 (recorded in 2023), while the average stood at $245775.3.
- Its Receivables - Other has fluctuated over the past 5 years, first surged by 6377406.67% in 2022, then plummeted by 9924.15% in 2023.
- Over the past 5 years, BioCorRx's Receivables - Other (Quarter) stood at $56359.0 in 2021, then skyrocketed by 117.63% to $122652.0 in 2022, then plummeted by 37.82% to $76266.0 in 2023, then soared by 311.94% to $314170.0 in 2024, then surged by 142.39% to $761515.0 in 2025.
- Its Receivables - Other stands at $761515.0 for Q3 2025, versus $153728.0 for Q2 2025 and $153360.0 for Q1 2025.